Eli Lilly and Co (LLY)
757.94
+24.65
(+3.36%)
USD |
NYSE |
May 16, 16:00
759.16
+1.22
(+0.16%)
After-Hours: 16:13
Eli Lilly Profit Margin (Quarterly): 21.68% for March 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 21.23% |
| Regeneron Pharmaceuticals Inc | 26.70% |
| Vertex Pharmaceuticals Inc | 23.33% |
| Viking Therapeutics Inc | -- |
| Moderna Inc | -907.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 78.24% |
| Return on Assets | 14.63% |
| Return on Invested Capital | 24.21% |
| Gross Profit Margin (Quarterly) | 82.53% |
| Operating Margin (Quarterly) | 42.49% |
| Return on Net Operating Assets | 19.52% |